Endpoints News ١٣ يناير ٢٠٢٦ FDA delays decision on expanding label for Travere's kidney disorder drug
Endpoints News ١٣ يناير ٢٠٢٦ Trump administration appears to have ended its US trade probe into pharma
Endpoints News ١٣ يناير ٢٠٢٦ VantAI gets $80M and new name; Dynavax discloses it had pre-Sanofi suitor
Endpoints News ١٣ يناير ٢٠٢٦ AbbVie reaches MFN deal with the White House, pledges billions to US manufacturing
Endpoints News ١٣ يناير ٢٠٢٦ Novartis licenses radiopharma asset from Chinese biotech for $50M upfront
Endpoints News ١٢ يناير ٢٠٢٦ #JPM26: Novo Nordisk CEO says pharma can learn from the GLP-1 compounding boom